Occlutech International Ab

This program provides expanded access to Occlutech's atrial flow regulator (AFR), a device designed to help manage certain heart conditions. It is available for patients who have no other treatment options and meet FDA criteria. The goal is to control the disease and improve hear…

This study looks at a device that closes a common heart hole called patent ductus arteriosus (PDA). About 255 people of any age who need this closure will be followed for up to 3 years after the procedure. The main goals are to see if the device is safe and if it successfully clo…

This study follows 150 heart failure patients who receive a device called the Occlutech Atrial Flow Regulator. The device is implanted to help manage symptoms by balancing pressure in the heart's upper chambers. Researchers will track safety and heart-related events for up to thr…

This study follows about 50 people of any age who receive a special device to close a hole in the muscular part of the heart's lower chambers. The goal is to confirm the device works well and is safe over one year. Researchers will check for serious side effects and whether the h…

This study is tracking the safety and performance of four specific tools (delivery set, pushers, and sizing balloon) used by doctors during heart implant procedures. About 685 people who receive these tools as part of their heart device implantation will be included. The goal is …